During a webcast yesterday titled “Cellular Health: The Next Big Market Opportunity“, Nestlé Health Science’s Joelle Legree spoke at great length explaining the strategy behind the recent launch of Celltrient. Of course, Celltrient is Nestlé Health’s (a Nestlé subsidiary) new brand focused on cellular health. And, for those interested in raising NAD levels, one of Celltrient’s three new products “Celltrient Energy” contains Nicotinamide Riboside “NR” (FAQs) (Reviews). How does Nestlé Health and its team of scientists feel about the NR vs NMN debate? Key quotes:

At the 66:30 mark of the “Cellular Health: The Next Big Market Opportunity” Webcast:

“…over the past 3 years, we have seen an explosion in the interest and science of supporting cellular mechanisms and the underlying causes of the hallmarks of aging.

This is evidenced in the number of clinical trials being conducted, studies being published, and even books being written.

…as Frank (Frank Jaksch, Chromadex) can attest to, we have engaged in over 200 research collaborations on Niagen / Nicotinamide Riboside (NR) alone.”

At the 67:30 mark of the webcast:

“…as Frank (Frank Jaksch, Chromadex) gave his example above, there’s NMN, but then there’s NR which is the most efficient NAD+ precursor…”

At the 71:15 mark of the webcast:

“…deep inside your body, an important molecule called NAD+ is declining.

NAD+ levels decline by as much as 50% as Frank (Frank Jaksch, Chromadex) has showed us.

And what this shortfall can lead to is tiredness and fatigue.

…as mentioned, with Celltrient Energy, which features Niagen or Nicotinamide Riboside (NR) and is clinically shown to increase NAD+ levels in as soon as 2 weeks.”

NOTE:

FOLLOW us on Twitter at @RaisingNAD